View in EDS HTML Full Text PDF Full Text

Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study.

Saved in:
Bibliographic Details
Title: Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study.
Authors: Fukushima, Masanori1 (AUTHOR) ma-fukushima@nagasaki-u.ac.jp, Miuma, Satoshi1 (AUTHOR), Nakao, Yasuhiko1 (AUTHOR), Sasaki, Ryu1 (AUTHOR), Haraguchi, Masafumi1 (AUTHOR), Miyaaki, Hisamitsu1 (AUTHOR)
Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 11, p4021. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm15114021